Genetics and diet shape insulin signaling in mice

BeiGene is ex­pand­ing its can­cer ar­se­nal with an an­ti­body-drug con­ju­gate deal, en­list­ing the same Shang­hai biotech that teamed up with BioN­Tech in April. The sol­id

A for­mer top ex­ec­u­tive at the gener­ic drug com­pa­ny Vi­a­tris had his in­sid­er trad­ing al­le­ga­tions dropped by the De­part­ment of Jus­tice two weeks be­fore the